期刊
INTERNATIONAL JOURNAL OF CARDIOLOGY
卷 236, 期 -, 页码 432-437出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2017.01.097
关键词
Pulmonary arterial hypertension; Systemic lupus erythematosus; Systemic sclerosis; Primary Sjogren's syndrome
资金
- Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2012AA02A513]
- Chinese National Key Technology R&D Program, Ministry of Science and Technology [2008BAI59B02, 2011BAI11B15]
Objective: Pulmonary arterial hypertension (PAH) is a major cause of death in connective tissue disease patients. This study investigated the clinical characteristics and survival of CTD-PAH in Chinese patients. Methods: This cohort study enrolled 190 consecutive PAH patients with systemic lupus erythematosus (SLE), systemic sclerosis (SSc), or primary Sjogren's syndrome (pSS) who visited our referral center between May 2006 and December 2014. Baseline demographics, clinical features, laboratory results, and hemodynamic assessments were analyzed. Cox proportional hazards regression analysis was used to identify independent factors associated with increased risk of mortality. Results: The PAH patients were more likely to have SLE (58.4%) as the underlying CTD than SSc (26.3%) or pSS (15.3%). Mean age was 37.8 +/- 10.4 years, and patients with SLE were youngest at the time of PAH diagnosis. The most prevalent autoantibody was anti-U1RNP antibody (55.8%). The three groups did not differ significantly regarding World Health Organization functional class or hemodynamic results. The overall 1-, 3-, and 5-year survival rates were 87.1%, 79.1%, and 62.9%, respectively. The 3-year survival rate of 81.3% for those with SLE-PAH was significantly better than that for patients with SSc-PAH (63.6%, P < 0.05). Independent predictors of mortality were 6-minute walk distance (6MWD) <= 380 m (HR 3.222, 95% CI 1.485-6.987, P = 0.003) and underlying CTD (HR 1.684; 95CI% 1.082-2.622, P = 0.021). Conclusion: Independent predictors of mortality for CTD-PAH were 6MWD <380 m and SSc as the underlying CTD. Increased awareness of pSS-PAH is needed because of its worse prognosis compared to SLE-PAH. (C) 2016 Published by Elsevier Ireland Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据